MCP AbD Serotec
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 1, 2006.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M600314-MCP200v1
5/12/2350    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kehoe, J. W.
Right arrow Articles by Bradbury, A. R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kehoe, J. W.
Right arrow Articles by Bradbury, A. R. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on August 16, 2006
Revised on August 31, 2006
Accepted on September 12, 2006

Using phage display to select antibodies recognizing post-translational modifications independently of sequence context

John W. Kehoe, Nileena Velappan, Monica Walbolt, Jytte Rasmussen, Dave King, Jianlong Lou, Kristeene Knopp, Peter Pavlik, James D. Marks, Carolyn R. Bertozzi, and Andrew R. M. Bradbury

Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545

Corresponding Author: amb{at}lanl.gov

Many cellular activities are controlled by post-translational modifications, the study of which is hampered by the lack of specific reagents, due in large part to their ubiquitous and non-immunogenic nature. Although antibodies against specifically modified sequences are relatively easy to obtain, it is extremely difficult to derive reagents recognizing post-translational modifications independently of the sequence context surrounding the modification. In this paper, we have examined the possibility of selecting such antibodies from large phage antibody libraries, using sulfotyrosine as a test case. Sulfotyrosine is a post-translational modification important in many extracellular protein-protein interactions, including HIV infection. After screening almost 8000 selected clones, we were able to isolate a single specific scFv, using two different selection stragies, one of which included elution with tyrosine sulfate. This antibody is able to recognize sulfotyrosine independently of its sequence context in test peptides and a number of different natural proteins. Antibody reactivity is lost by antigen treatment with sulfatase, or preincubation with soluble tyrosine sulfate, indicating its specificity. The isolation of this antibody signals the potential of phage antibody libraries in the derivation of reagents specific for post-translational modifications, although the extensive screening required indicates that such antibodies are extremely rare.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Eng Des SelHome page
H. Persson, H. Wallmark, A. Ljungars, J. Hallborn, and M. Ohlin
In vitro evolution of an antibody fragment population to find high-affinity hapten binders
Protein Eng. Des. Sel., August 1, 2008; 21(8): 485 - 493.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
F. An, D. C. Drummond, S. Wilson, D. B. Kirpotin, S. L. Nishimura, V. C. Broaddus, and B. Liu
Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies
Mol. Cancer Ther., March 1, 2008; 7(3): 569 - 578.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
B. Liu
Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA
Brief Funct Genomic Proteomic, July 31, 2007; (2007) elm015v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.